SlideShare a Scribd company logo
1 of 28
Colonic Stenting Alessandro Repici, MD Digestive Endoscopy Unit Department of Gastroenterology IRCCS Istituto Clinico Humanitas, Milano, Italy
Large Bowel Obstruction (LBO)
Large Bowel Malignant Obstruction ,[object Object],[object Object],[object Object],[object Object]
 
LBO: the management ,[object Object],[object Object],[object Object],[object Object]
S. Breitenstein, et al; Systematic evaluation of surgical strategies for acute malignant left-sided colonic  obstruction;  British Journal of Surgery 2007; 94: 1451–1460 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Surgical management of malignant LBO
Colonic Stenting ,[object Object],[object Object],[object Object],[object Object],[object Object]
Technical issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Technique ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],To me, emergency colorectal stenting may be one of the  most challenging operative procedures in GI endoscopy The Technique
 
Baron TH, Endoscopy 2010
first 25-30 cm Rest of colon OTW STENT TTS STENT
 
 
Pooled analysis of clinical and technical success rates   (54 trials – 1198 patients) Sebastian S et al. Am J Gastroenterol 2004 Group Number Cumulative  Range  Technical  success Overall 1198 93% 64-100 Palliative  791 93% 67-100 Bridge to surgery 407 92% 33-100 Clinical  success Overall 1198 89% 55-100 Palliative  791 91% 62-100 Bridge to surgery 407 72% 45-84
Br J Surgery 2007
Arch Surg 2009
Repici A et al GIE 2008  Long-term palliation
SEMS-related complications ,[object Object],[object Object],[object Object]
There is concern about risk of perforation Van Hooft J et al Endoscopy 2008
Author Journal Pts Palliation/ BTS Type of stent Complications (%) Perforations (%) Law WL Colorectal Dis 2010 130 101/29 Esoph.Wallstent Colon Wallflex Choostent Enteral Wallstent Ultraflex 20 1,5 Baraza W. Colorectal Dis 2008 63 56/7 Niti-S Bard Memotherm 25 0 M. Alcantara Tech Coloproctol 2007 95 (103 SEMS) 28/67 Enteral Wallstent Esophacoil Hanaro stent Wallflex 13.7 4.2 Giovannini MD J clin Gastroenterol 2008 36 (52 SEMS) 36/0 Choostent Wallstent Hanaro stent 35 7.5 Brehant O Colorectal Dis 2009 30 0/30 Wallflex 23 7 Min Kyu Jung Surg Endosc 2009 39 39/0 Niti-S Hanarostent Wallflex Early 12.8 Late 11.8 Early 2.6 Late 2.9 S. Mucci-Hennekinne Surg Endosc 2007 67 55/12 Hanarostent ? 6,2 Repici A Gastroint Endosc 2008 42 23/19 Wallflex Early 9.5 Late 14.3 2.4 Jong Pil Im Int J Colorectal Dis 2008 49 pts (51SEMS) 49/0 Hanaro MI Tech 24 2
Small AJ et al. GIE 2010 Bevacizumab-based therapies and  Colonic perforation after SEMS placement Is it time for a warning? Bevacizumab-based therapies Treated Untreated P 15.4% 6.8% 0.06
Cennamo V et al Clin Gastroenterol Hepatol 2009
49 y old lady: Feb-July 2009  FOLFOX4   Sept 2009-Jan 2010  FOLFIRI+Bevacizumab Feb 02 2010 Feb 04 2010 March 11 2010
Hapani S, et al Lancet Oncology 2009
Proper selection of patients for palliation with metal stents is a key-factor ,[object Object],[object Object],[object Object],[object Object]
Conclusions: Colonic Stenting ,[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Management of colorectal liver metastasis
Management of colorectal liver metastasis Management of colorectal liver metastasis
Management of colorectal liver metastasis
Aditya Punamiya
 
Hilar Cholangiocarcinoma
Hilar Cholangiocarcinoma Hilar Cholangiocarcinoma
Hilar Cholangiocarcinoma
Dr Harsh Shah
 

What's hot (20)

Bile duct injuries in Laparocsopic cholecystectomy
Bile duct injuries in Laparocsopic cholecystectomyBile duct injuries in Laparocsopic cholecystectomy
Bile duct injuries in Laparocsopic cholecystectomy
 
Obstructive defecation syndrome
Obstructive defecation syndromeObstructive defecation syndrome
Obstructive defecation syndrome
 
Liver and Biliary Trauma
Liver and Biliary TraumaLiver and Biliary Trauma
Liver and Biliary Trauma
 
MANAGEMENT OF HEPATOCELLULAR CARCINOMA
MANAGEMENT OF HEPATOCELLULAR CARCINOMAMANAGEMENT OF HEPATOCELLULAR CARCINOMA
MANAGEMENT OF HEPATOCELLULAR CARCINOMA
 
Management of pancreatic fistulas
Management of pancreatic fistulasManagement of pancreatic fistulas
Management of pancreatic fistulas
 
Safe laparoscopic cholecystectomy finale
Safe laparoscopic cholecystectomy finaleSafe laparoscopic cholecystectomy finale
Safe laparoscopic cholecystectomy finale
 
Iatrogenic biliary tract injuries
Iatrogenic biliary tract  injuries Iatrogenic biliary tract  injuries
Iatrogenic biliary tract injuries
 
Liver Trauma & Concepts in Abdominal Trauma Lecture
Liver Trauma & Concepts in Abdominal Trauma LectureLiver Trauma & Concepts in Abdominal Trauma Lecture
Liver Trauma & Concepts in Abdominal Trauma Lecture
 
SAFE LAPAROSCOPIC CHOLECYSTECTOMY
SAFE LAPAROSCOPIC CHOLECYSTECTOMYSAFE LAPAROSCOPIC CHOLECYSTECTOMY
SAFE LAPAROSCOPIC CHOLECYSTECTOMY
 
D2 gastrectomy
D2 gastrectomyD2 gastrectomy
D2 gastrectomy
 
Management of colorectal liver metastasis
Management of colorectal liver metastasis Management of colorectal liver metastasis
Management of colorectal liver metastasis
 
Hilar Cholangiocarcinoma
Hilar Cholangiocarcinoma Hilar Cholangiocarcinoma
Hilar Cholangiocarcinoma
 
Multidisciplinary Approach to Colorectal Liver Metastases
Multidisciplinary Approach to Colorectal Liver MetastasesMultidisciplinary Approach to Colorectal Liver Metastases
Multidisciplinary Approach to Colorectal Liver Metastases
 
Basic principle of liver resection
Basic principle of liver resectionBasic principle of liver resection
Basic principle of liver resection
 
Functional liver residue-- All we need to know
Functional liver residue-- All we need to knowFunctional liver residue-- All we need to know
Functional liver residue-- All we need to know
 
Bile duct injuries
Bile duct injuriesBile duct injuries
Bile duct injuries
 
Minimal invasive Surgery in Management of colorectal cancer
Minimal invasive Surgery in Management of colorectal cancerMinimal invasive Surgery in Management of colorectal cancer
Minimal invasive Surgery in Management of colorectal cancer
 
Bile duct injuries BDI
Bile duct injuries BDIBile duct injuries BDI
Bile duct injuries BDI
 
Laparoscopic colorectal cancer surgery trials
Laparoscopic colorectal cancer surgery trialsLaparoscopic colorectal cancer surgery trials
Laparoscopic colorectal cancer surgery trials
 
CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA
 

Similar to Endoscopy in Gastrointestinal Oncology - Slide 19 - A. Repici - Colorectal stents

Urgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic ReassessmentUrgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic Reassessment
George S. Ferzli
 
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
European School of Oncology
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
European School of Oncology
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
European School of Oncology
 
Laparoscopic trans hiatal esophagectomy for early cancer-final
Laparoscopic trans hiatal esophagectomy for early cancer-finalLaparoscopic trans hiatal esophagectomy for early cancer-final
Laparoscopic trans hiatal esophagectomy for early cancer-final
foregutsurgeon
 
Open Versus Laparoscopic Surgery What is A Myth and What is Not!
Open Versus Laparoscopic Surgery What is A Myth and What is Not!Open Versus Laparoscopic Surgery What is A Myth and What is Not!
Open Versus Laparoscopic Surgery What is A Myth and What is Not!
George S. Ferzli
 
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
European School of Oncology
 
Complications of pud
Complications of pudComplications of pud
Complications of pud
Avid Listener
 

Similar to Endoscopy in Gastrointestinal Oncology - Slide 19 - A. Repici - Colorectal stents (20)

Lo stent nelle occlusioni neoplastiche del Colon - Gastrolearning®
Lo stent nelle occlusioni neoplastiche del Colon - Gastrolearning®Lo stent nelle occlusioni neoplastiche del Colon - Gastrolearning®
Lo stent nelle occlusioni neoplastiche del Colon - Gastrolearning®
 
Obstructed recto sigmoid malignancy
Obstructed recto sigmoid malignancyObstructed recto sigmoid malignancy
Obstructed recto sigmoid malignancy
 
Urgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic ReassessmentUrgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic Reassessment
 
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
Endoscopy in Gastrointestinal Oncology - Slide 11 - G. Vanbiervliet - Indicat...
 
Acutely Obstructing Colorectal Cancer – Treatment Options- Jim Hill
Acutely Obstructing Colorectal Cancer – Treatment Options- Jim HillAcutely Obstructing Colorectal Cancer – Treatment Options- Jim Hill
Acutely Obstructing Colorectal Cancer – Treatment Options- Jim Hill
 
esophageal cancer surgery types and complications
esophageal cancer surgery types and complicationsesophageal cancer surgery types and complications
esophageal cancer surgery types and complications
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
 
Laparoscopic trans hiatal esophagectomy for early cancer-final
Laparoscopic trans hiatal esophagectomy for early cancer-finalLaparoscopic trans hiatal esophagectomy for early cancer-final
Laparoscopic trans hiatal esophagectomy for early cancer-final
 
Laparoscopic Management of Emergency UpperGI Perfofations
Laparoscopic Management of Emergency UpperGI PerfofationsLaparoscopic Management of Emergency UpperGI Perfofations
Laparoscopic Management of Emergency UpperGI Perfofations
 
JBCPS - Ileostomy closure (PDF)
JBCPS - Ileostomy closure (PDF) JBCPS - Ileostomy closure (PDF)
JBCPS - Ileostomy closure (PDF)
 
Open Versus Laparoscopic Surgery What is A Myth and What is Not!
Open Versus Laparoscopic Surgery What is A Myth and What is Not!Open Versus Laparoscopic Surgery What is A Myth and What is Not!
Open Versus Laparoscopic Surgery What is A Myth and What is Not!
 
Ulcera perforada
Ulcera perforadaUlcera perforada
Ulcera perforada
 
EPIPHRENIC ESOPHAGEAL DIVERTICULUM
EPIPHRENIC ESOPHAGEAL DIVERTICULUMEPIPHRENIC ESOPHAGEAL DIVERTICULUM
EPIPHRENIC ESOPHAGEAL DIVERTICULUM
 
La terapia medica e chirurgica della malattia perianale di Crohn - Gastrolear...
La terapia medica e chirurgica della malattia perianale di Crohn - Gastrolear...La terapia medica e chirurgica della malattia perianale di Crohn - Gastrolear...
La terapia medica e chirurgica della malattia perianale di Crohn - Gastrolear...
 
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
Endoscopy in Gastrointestinal Oncology - Slide 16 - J. East - Colonoscopy, vi...
 
Small bowel obstruction and Intestinal Fistulas
Small bowel obstruction and Intestinal FistulasSmall bowel obstruction and Intestinal Fistulas
Small bowel obstruction and Intestinal Fistulas
 
Complications of pud
Complications of pudComplications of pud
Complications of pud
 
MCC 2011 - Slide 19
MCC 2011 - Slide 19MCC 2011 - Slide 19
MCC 2011 - Slide 19
 
Palliation of malignant dysphagia3
Palliation of malignant dysphagia3Palliation of malignant dysphagia3
Palliation of malignant dysphagia3
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
European School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
European School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
European School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
European School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
European School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
European School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
European School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

Endoscopy in Gastrointestinal Oncology - Slide 19 - A. Repici - Colorectal stents

  • 1. Colonic Stenting Alessandro Repici, MD Digestive Endoscopy Unit Department of Gastroenterology IRCCS Istituto Clinico Humanitas, Milano, Italy
  • 3.
  • 4.  
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.  
  • 13. first 25-30 cm Rest of colon OTW STENT TTS STENT
  • 14.  
  • 15.  
  • 16. Pooled analysis of clinical and technical success rates (54 trials – 1198 patients) Sebastian S et al. Am J Gastroenterol 2004 Group Number Cumulative Range Technical success Overall 1198 93% 64-100 Palliative 791 93% 67-100 Bridge to surgery 407 92% 33-100 Clinical success Overall 1198 89% 55-100 Palliative 791 91% 62-100 Bridge to surgery 407 72% 45-84
  • 17. Br J Surgery 2007
  • 19. Repici A et al GIE 2008 Long-term palliation
  • 20.
  • 21. There is concern about risk of perforation Van Hooft J et al Endoscopy 2008
  • 22. Author Journal Pts Palliation/ BTS Type of stent Complications (%) Perforations (%) Law WL Colorectal Dis 2010 130 101/29 Esoph.Wallstent Colon Wallflex Choostent Enteral Wallstent Ultraflex 20 1,5 Baraza W. Colorectal Dis 2008 63 56/7 Niti-S Bard Memotherm 25 0 M. Alcantara Tech Coloproctol 2007 95 (103 SEMS) 28/67 Enteral Wallstent Esophacoil Hanaro stent Wallflex 13.7 4.2 Giovannini MD J clin Gastroenterol 2008 36 (52 SEMS) 36/0 Choostent Wallstent Hanaro stent 35 7.5 Brehant O Colorectal Dis 2009 30 0/30 Wallflex 23 7 Min Kyu Jung Surg Endosc 2009 39 39/0 Niti-S Hanarostent Wallflex Early 12.8 Late 11.8 Early 2.6 Late 2.9 S. Mucci-Hennekinne Surg Endosc 2007 67 55/12 Hanarostent ? 6,2 Repici A Gastroint Endosc 2008 42 23/19 Wallflex Early 9.5 Late 14.3 2.4 Jong Pil Im Int J Colorectal Dis 2008 49 pts (51SEMS) 49/0 Hanaro MI Tech 24 2
  • 23. Small AJ et al. GIE 2010 Bevacizumab-based therapies and Colonic perforation after SEMS placement Is it time for a warning? Bevacizumab-based therapies Treated Untreated P 15.4% 6.8% 0.06
  • 24. Cennamo V et al Clin Gastroenterol Hepatol 2009
  • 25. 49 y old lady: Feb-July 2009 FOLFOX4 Sept 2009-Jan 2010 FOLFIRI+Bevacizumab Feb 02 2010 Feb 04 2010 March 11 2010
  • 26. Hapani S, et al Lancet Oncology 2009
  • 27.
  • 28.